Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 13,624 | 13,671 | 8,764 | 3,800 | 982 |
| Cost of Goods | 985 | 312 | 332 | 240 | 437 |
| Gross Profit | 12,639 | 13,359 | 8,432 | 3,559 | 545 |
| Operating Expenses | 67,882 | 72,130 | 59,199 | 31,950 | 16,565 |
| Operating Income | -54,258 | -58,458 | -50,435 | -28,150 | -15,583 |
| Other Income | 1,016 | 98 | 1,718 | 4,254 | 831 |
| Pre-tax Income | -53,242 | -58,361 | -48,717 | -23,896 | -14,752 |
| Income Tax | N/A | N/A | -63 | N/A | N/A |
| Net Income Continuous | -53,242 | -58,361 | -48,654 | -23,896 | -14,752 |
| Net Income | $-53,242 | $-58,361 | $-48,654 | $-23,896 | $-14,752 |
| EPS Basic Total Ops | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 |
| EPS Basic Continuous Ops | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 |
| EPS Diluted Total Ops | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 |
| EPS Diluted Continuous Ops | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 |
| EBITDA(a) | $-52,750 | $-57,015 | $-49,387 | $-27,574 | $-15,339 |